Adverse mucocutaneous reactions to chemotherapeutic agents - Part I

被引：13

作者：

Sanches, Jose Antonio, Jr.

Clivati Brandt, Hebert Roberto ^{[1
]}

Duarte Moure, Emanuella Rosyane

Stelko Pereira, Guilherme Luiz ^{[2
]}

Criado, Paulo Ricardo ^{[3
,4
]}

机构：

[1] Univ Sao Paulo FMUSP, Fac Med, Clin Hosp, Dept Dermatol, Sao Paulo, Brazil

[2] Univ Sao Paulo FMUSP, Fac Med, Div Clin Oncol, Canc Inst Sao Paulo, Sao Paulo, Brazil

[3] Univ Sao Paulo FMUSP, Div Clin Dermatol, Sao Paulo, Brazil

[4] Univ Sao Paulo FMUSP, Med Invest Lab, Clin Hosp, Fac Med, Sao Paulo, Brazil

来源：

ANAIS BRASILEIROS DE DERMATOLOGIA | 2010年 / 85卷 / 04期

关键词：

Chemotherapy; adjuvant; Drug therapy; combination; Skin; Skin abnormalities; Skin pigmentation; NEUTROPHILIC ECCRINE HIDRADENITIS; INDUCED ACRAL ERYTHEMA; GROWTH-FACTOR RECEPTOR; VERSUS-HOST-DISEASE; OF-THE-LITERATURE; SQUAMOUS SYRINGOMETAPLASIA; CUTANEOUS REACTIONS; FOOT-SYNDROME; INDUCED ALOPECIA; ORAL MUCOSITIS;

D O I：

10.1590/S0365-05962010000400003

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

The local and systemic treatment of tumors can cause changes in the skin, mucous membranes, hair and nails. Accurate diagnosis and appropriate treatment of side effects require knowledge about the patterns of the most common adverse reactions to drugs the patient may be using. The dermatologist must be familiar with the manifestations of certain soft tissue neoplasms, as well as with the adverse mucocutaneous forms of cancer treatment.

引用

收藏

页码：425 / 434

页数：10

相关论文

共 70 条

[1] Cutaneous toxicities of cancer therapy [J].

Alley, E ;

Green, R ;

Schuchter, L .

CURRENT OPINION IN ONCOLOGY, 2002, 14 (02) :212-216

[2] Infectious eccrine hidradenitis caused by Nocardia [J].

Antonovich, DD ;

Berke, A ;

Grant-Kels, JM ;

Fung, M .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (02) :315-318

[3] CHEMOTHERAPY-INDUCED ACRAL ERYTHEMA [J].

BAACK, BR ;

BURGDORF, WHC .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1991, 24 (03) :457-461

[4] Eccrine squamous syringometaplasia and cytomegalovirus infection [J].

Baysse, L ;

Boralevi, F ;

Lepreux, S ;

Boyer, A ;

Morel, C ;

Léauté-Labrèze, C ;

Taïeb, A .

REVUE DE MEDECINE INTERNE, 2003, 24 (06) :394-398

[5] Palifermin: a keratinocyte growth factor that reduces oral mucositis after stem cell transplant for haematological malignancies [J].

Beaven, Anne W. ;

Shea, Thomas C. .

EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (16) :2287-2299

[6] Adult idiopathic neutrophilic eccrine hidradenitis treated with colchicine [J].

Belot, Veronique ;

Perrinaud, Adeline ;

Corven, Cloe ;

de Muret, Anne ;

Lorette, Gerard ;

Machet, Laurent .

PRESSE MEDICALE, 2006, 35 (10) :1475-1478

[7] RECURRENT NEUTROPHILIC ECCRINE HIDRADENITIS [J].

BERNSTEIN, EF ;

SPIELVOGEL, RL ;

TOPOLSKY, DL .

BRITISH JOURNAL OF DERMATOLOGY, 1992, 127 (05) :529-533

[8] Epidermal growth factor receptor inhibitor-related skin toxicity: Mechanisms, treatment, and its potential role as a predictive marker [J].

Bianchini, Diletta ;

Jayanth, Akali ;

Chua, Yu Jo ;

Cunningham, David .

CLINICAL COLORECTAL CANCER, 2008, 7 (01) :33-43

[9] Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis [J].

Blijlevens, N. ;

Sonis, S. .

ANNALS OF ONCOLOGY, 2007, 18 (05) :817-826

[10] Toxic erythema of chemotherapy: A useful clinical term [J].

Bolognia, Jean L. ;

Cooper, Dennis L. ;

Glusac, Earl J. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 59 (03) :524-529

← 1 2 3 4 5 6 7 →